Ocean Biomedical Inc. (OCEA)
NASDAQ: OCEA
· Real-Time Price · USD
0.01
0.00 (26.58%)
At close: Jun 09, 2025, 3:19 PM
Ocean Biomedical Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | n/a | -1.75M | -768K | -682K | -595K | 660K | -2.65M | -2.68M | -5.22M | -614.18K | -1.37M | -6.9M | -5.11M | -8.18M | -4.89M | -5.34M | -43.94M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.02M | 351.77K | 140.3K | 6.91K | 2.27K | n/a | n/a | n/a |
Pretax Income | -8.24M | 6.46M | -5.53M | -17.23M | 13M | -16.86M | -14.09M | -13.03M | -67.4M | 410.05K | -1.02M | -7.33M | -5.38M | -8.18M | -4.89M | -5.34M | -43.94M |
Net Income | -8.24M | 6.46M | -5.53M | -17.23M | 13M | -16.86M | -14.09M | -13.03M | -128.04M | 410.05K | -1.02M | -7.77M | -5.37M | -8.18M | -4.88M | -5.34M | -43.94M |
Selling & General & Admin | 940K | 1.75M | 768K | 682K | 569K | -643K | 2.35M | 2.65M | 4.83M | 614.18K | 1.37M | 3.71M | 1.91M | 4.98M | 2.23M | 2.68M | 18.53M |
Research & Development | 18K | n/a | n/a | n/a | 26K | -17K | 305K | 28K | 393K | n/a | 1.86M | 3.19M | 3.2M | 3.19M | 2.66M | 2.66M | 25.41M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -12.68M | n/a | 1K | -699K | 1K | n/a | 2K | n/a | n/a |
Operating Expenses | 958K | 1.75M | 768K | 682K | 595K | -660K | 2.65M | 2.68M | 5.22M | 614.18K | 1.37M | 6.9M | 5.11M | 8.18M | 4.89M | 5.34M | 43.94M |
Interest Expense | n/a | 433K | 461K | 515K | 637K | 500K | 293K | 668K | 1.54M | -624.29K | 61K | 433K | 266K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 54.6K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 1.75M | 768K | 682K | 595K | -660K | 2.65M | 2.68M | 5.22M | 614.18K | 1.37M | 6.9M | 5.11M | 8.18M | 4.89M | 5.34M | 43.94M |
Income Tax Expense | n/a | -3.3M | n/a | n/a | n/a | n/a | n/a | 668K | 60.63M | -54.88K | -27.08K | 433K | -1K | -69.11K | -2K | 1K | -55.21K |
Shares Outstanding (Basic) | 27.5M | 27.5M | 27.49M | 27.49M | 27.34M | 27.34M | 26.61M | 26.47M | 24.82M | 13.22M | 13.22M | 10.6M | 11.91M | 13.2M | 13.47M | 13.47M | 16.84M |
Shares Outstanding (Diluted) | 27.5M | 27.5M | 27.49M | 27.49M | 27.34M | 27.34M | 26.61M | 26.47M | 24.82M | 13.22M | 13.22M | 10.6M | 11.91M | 13.2M | 13.47M | 13.47M | 16.84M |
EPS (Basic) | -0.3 | 0.23 | -0.2 | -0.63 | 0.48 | -0.62 | -0.53 | -0.49 | -5.16 | 0.03 | -0.08 | -0.73 | -0.45 | -0.62 | -0.36 | -0.4 | -2.61 |
EPS (Diluted) | -0.3 | 0.23 | -0.2 | -0.63 | 0.48 | -0.62 | -0.53 | -0.49 | -5.16 | 0.03 | -0.08 | -0.73 | -0.45 | -0.62 | -0.36 | -0.4 | -2.61 |
EBITDA | n/a | 716K | -5.07M | -16.72M | 13.64M | -16.36M | -13.79M | -10.76M | -71.79M | 15.29M | -3.61M | -7.28M | -5.36M | -8.18M | -4.89M | -5.34M | -43.94M |
EBIT | n/a | 8.15M | -5.07M | -16.72M | 13.64M | -16.36M | -13.79M | -10.76M | -71.79M | 15.29M | -3.61M | -7.28M | -5.36M | -8.18M | -4.89M | -5.34M | -43.94M |
Depreciation & Amortization | n/a | 1.81M | n/a | -16.04M | 14.23M | -17.02M | -11.14M | -1K | -12.68M | 54.88K | 27.08K | -1K | 1K | 71.39K | 54K | 55.81K | 55.21K |